capital markets: Piramal Pharma’s Rs 1,050-cr rights issue gets Sebi’s nod
Piramal Pharma has received capital markets regulator Sebi’s go-ahead to raise up to Rs 1,050 crore through rights issue of shares. The pharma firm, which filed draft papers with the …